Squarepoint’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-170,172
Closed -$96.3K 2921
2025
Q1
$96.3K Buy
+170,172
New +$96.3K ﹤0.01% 2532
2024
Q3
Sell
-19,647
Closed -$56K 2722
2024
Q2
$56K Buy
+19,647
New +$56K ﹤0.01% 2346
2023
Q4
Sell
-10,743
Closed -$46.2K 2682
2023
Q3
$46.2K Buy
+10,743
New +$46.2K ﹤0.01% 2332
2023
Q2
Sell
-12,990
Closed -$54.6K 2564
2023
Q1
$54.6K Buy
12,990
+2,364
+22% +$9.93K ﹤0.01% 2099
2022
Q4
$29.4K Sell
10,626
-7,202
-40% -$20K ﹤0.01% 2181
2022
Q3
$46K Buy
17,828
+2,400
+16% +$6.19K ﹤0.01% 1949
2022
Q2
$56K Buy
+15,428
New +$56K ﹤0.01% 1949
2022
Q1
Sell
-13,397
Closed -$94K 2481
2021
Q4
$94K Buy
13,397
+822
+7% +$5.77K ﹤0.01% 2318
2021
Q3
$88K Sell
12,575
-11,384
-48% -$79.7K ﹤0.01% 2030
2021
Q2
$200K Sell
23,959
-9,198
-28% -$76.8K ﹤0.01% 2235
2021
Q1
$181K Buy
+33,157
New +$181K ﹤0.01% 2191
2020
Q4
Sell
-24,752
Closed -$75K 2662
2020
Q3
$75K Buy
+24,752
New +$75K ﹤0.01% 2166
2020
Q2
Sell
-19,497
Closed -$43K 2265
2020
Q1
$43K Sell
19,497
-48,042
-71% -$106K ﹤0.01% 1723
2019
Q4
$206K Buy
67,539
+51,799
+329% +$158K ﹤0.01% 2121
2019
Q3
$48K Sell
15,740
-101,318
-87% -$309K ﹤0.01% 2141
2019
Q2
$234K Buy
117,058
+63,416
+118% +$127K ﹤0.01% 1979
2019
Q1
$231K Sell
53,642
-43,950
-45% -$189K ﹤0.01% 1834
2018
Q4
$310K Buy
97,592
+41,495
+74% +$132K ﹤0.01% 1479
2018
Q3
$295K Buy
56,097
+44,788
+396% +$236K ﹤0.01% 1542
2018
Q2
$61K Buy
+11,309
New +$61K ﹤0.01% 1679
2016
Q3
Sell
-11,200
Closed -$32K 1105
2016
Q2
$32K Buy
+11,200
New +$32K ﹤0.01% 1047